FDA Inspection 1277643 — Fresenius Kabi iPSUM Srl

Fresenius Kabi iPSUM Srl — FEI 3005479678

The FDA completed an inspection of Fresenius Kabi iPSUM Srl on January 21, 2022 in Villadose. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 21, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Villadose (Italy)

Additional Details

Mutual Recognition Agreement (MRA)